List of Excipients in API tucatinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tucatinib
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
SEAGEN INC | TUKYSA | tucatinib | 51144-001 | COPOVIDONE K25-31 | 2032-10-12 |
SEAGEN INC | TUKYSA | tucatinib | 51144-001 | CROSPOVIDONE | 2032-10-12 |
SEAGEN INC | TUKYSA | tucatinib | 51144-001 | FERRIC OXIDE YELLOW | 2032-10-12 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for tucatinib
Excipient focus: COPOVIDONE K25-31
tucatinib drug variants containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
tucatinib drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
tucatinib drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
tucatinib drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
tucatinib drug variants containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
tucatinib drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
tucatinib drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
tucatinib drug variants containing POTASSIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing POTASSIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
tucatinib drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
tucatinib drug variants containing SODIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing SODIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
tucatinib drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
tucatinib drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
tucatinib drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
SEAGEN INC | tucatinib | 51144-001 |
>Company | >Ingredient | >NDC |
tucatinib drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.